Revisions NeuBase Therapeutics, Inc. Nasdaq

Equities

NBSE

US64132K2015

Delayed Nasdaq 04:30:00 2024-05-10 pm EDT 5-day change 1st Jan Change
0.378 USD -3.20% Intraday chart for NeuBase Therapeutics, Inc. 0.00% -48.93%

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

EBIT

  1. Stock Market
  2. Equities
  3. O7P Stock
  4. NBSE Stock
  5. Revisions NeuBase Therapeutics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW